Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials - Concepedia

Concepedia

Publication | Open Access

Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials

DOI Full Paper Access

20

Citations

40

References

2021

Year

Sarah Harris, Bruce Cree, Douglas L. Arnold, Lawrence Steinman, James K. Sheffield, Harry Southworth, Ludwig Kappos, Jeffrey A. Cohen

European Journal of Neurology

Abstract

pNfL was associated with clinical and radiologic measures of disease and treatment effects in RMS, supporting its use as a biomarker.

References

	Year	Citations

Page 1